PI: Prof.dr. Michel Zwaan
Phone 00 31 (0) 88 972 52 03
The research program on myeloid leukemias is done in close collaboration with the Stam group and includes identifying determinants of clinical outcome to improve risk-group stratification, and to identify novel options for targeted treatment. Down ALL projects are performed in close collaboration with the Den Boer group.
The early clinical trial program includes early phase studies of promising novel compounds requiring development in pediatric oncology, but also studies on therapeutic drug monitoring, bioequivalence studies of novel pediatric formulations and age-dependent pharmacokinetics
Each of the units has a dedicated pediatric oncologist with a focus on early clinical trials:
Hematological malignancies
- Inge van der Sluis
- Britta Vormoor
- Auke Beishuizen (lymphoma)
- Caroline Lindemans (SCT)
- Natasha van Eijkelenburg
- Miranda Dierselhuis (fellow)
Brain tumors - Jasper van der Lugt
- Dannis van Vuurden (pontine glioma)
Prof.dr. Michel Zwaan's publications can be found on PubMed.
